{'fraction_non_alphanumeric': 0.01788617886178862, 'fraction_numerical': 0.0065040650406504065, 'mean_word_length': 4.6728110599078345, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Genomics in precision medicine

The term Precision Medicine (PM) gained significant attention in the field of drug discovery. The roots of PM can be traced back even before the start of Human Genome Project (in the early 2000s) but came into existence only by 2010. PM is a preventative strategy that focuses on improved patient care by taking account on variability in genes, environment, and lifestyle for each individual. PM is a long-term endeavour, including the National Institute of Health (NIH) and multiple other research centres were pioneers in funding and conducting cutting edge research related to PM. Knowing the genetic makeup of an individual will help us better understand and predict the risk of disease, this will further aid in    personalised diagnosis and treatment strategies. Although there has been significant number of research articles available on PM, however to the best of my knowledge they do not emphasise much on the reasons why PM has not been the choice for disease diagnosis and patient care. Therefore, this article will explain how PM will transform the future of heath care as we know it today. In addition, this article also discusses on factors that will aid in the development of PM. 
 